Steroids in Acute Bronchitis
Do not prescribe systemic or inhaled corticosteroids for uncomplicated acute bronchitis in otherwise healthy adults—they provide no clinical benefit and are not recommended by current guidelines. 1, 2
Primary Recommendation
Both oral and inhaled corticosteroids should not be routinely prescribed for immunocompetent adult outpatients with acute bronchitis because no evidence demonstrates safety or efficacy in reducing cough severity or duration. 1, 2
The CHEST 2020 expert panel issued an ungraded consensus-based statement against routine prescription of inhaled corticosteroids, oral corticosteroids, and all other pharmacologic therapies until treatments are proven safe and effective. 1
This recommendation applies specifically to uncomplicated acute bronchitis—a self-limited viral illness lasting 1–3 weeks in adults without underlying lung disease. 2, 3
Supporting Evidence
A systematic review of inhaled corticosteroids for acute respiratory tract infection–related cough (4 trials, 335 participants) found mixed and inconclusive results, with most trials showing equivalence to placebo and insufficient evidence to recommend routine use. 4
No randomized controlled trials have evaluated oral corticosteroids for acute bronchitis specifically, leaving a complete evidence gap for systemic steroid therapy in this condition. 4
Short-term systemic corticosteroids carry documented harms even in brief courses, including hyperglycemia, elevated blood pressure, mood disturbance, sepsis risk, fracture, and venous thromboembolism—risks that outweigh any theoretical benefit in viral bronchitis. 5
When Corticosteroids May Be Appropriate
Reassess for alternative diagnoses if symptoms persist beyond 3 weeks or worsen, particularly considering asthma exacerbation, COPD exacerbation, or bronchiectasis—conditions that may warrant corticosteroid therapy. 1, 2
Up to 65% of patients labeled with "recurrent acute bronchitis" actually have undiagnosed mild asthma, a critical diagnostic pitfall where inhaled corticosteroids would be indicated. 2, 6
COPD exacerbations (not simple acute bronchitis) may require oral corticosteroids when bacterial infection is suspected based on increased sputum purulence plus increased dyspnea and/or sputum volume. 6
Common Clinical Pitfalls
Do not prescribe steroids based on purulent or discolored sputum alone—sputum color reflects inflammatory cells and sloughed epithelium, not bacterial infection requiring treatment. 2, 6
Avoid misdiagnosing recurrent viral bronchitis when the patient actually has underlying reactive airway disease; look for patterns of similar episodes, wheezing, or response to bronchodilators. 2, 6
Despite guideline recommendations, real-world data show 70% of urgent care patients with prolonged acute cough receive systemic corticosteroids, representing significant overuse contrary to evidence. 7
Diagnostic Algorithm
Confirm the diagnosis of acute bronchitis in an otherwise healthy adult without chronic lung disease (asthma, COPD, bronchiectasis). 2
Rule out pneumonia by checking vital signs—if heart rate ≤100 bpm, respiratory rate ≤24/min, temperature ≤38°C, and chest exam is normal, pneumonia is very unlikely and chest X-ray is unnecessary. 2, 6, 3
Exclude alternative diagnoses such as asthma (look for wheezing, prior similar episodes), COPD exacerbation (smoking history, known disease), or pertussis (paroxysmal cough >2–3 weeks, community transmission). 2, 6
Do not prescribe corticosteroids (inhaled or oral), antibiotics, or other pharmacologic agents for symptom control. 1, 2
Educate the patient that cough typically lasts 2–3 weeks and is self-limited; this communication improves satisfaction without medication. 2, 8
Advise return for reassessment if cough persists beyond 3 weeks, worsens, or new concerning features develop (fever, dyspnea, hemoptysis). 2, 8